Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
12/1999
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064004A1 QUINAZOLINONE INHIBITORS OF cGMP PHOSPHODIESTERASE
12/16/1999WO1999064002A1 Spiropiperidine derivatives as melanocortin receptor agonists
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063980A1 Treatment of anti-estrogen resistant breast cancer using rxr modulators
12/16/1999WO1999063974A2 Selective estrogen receptor modulator in combination with denydroepiandrosterone (dhea) or analogues
12/16/1999WO1999063973A2 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
12/16/1999WO1999063967A1 Enhanced intra vaginal devices
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063931A2 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999WO1999041375A3 Human receptor proteins
12/16/1999CA2768882A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768841A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768828A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768773A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2768682A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999CA2334979A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999CA2334970A1 Quinazolinone inhibitors of cgmp phosphodiesterase
12/16/1999CA2334945A1 Imidazolyl derivatives
12/16/1999CA2334812A1 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor
12/16/1999CA2334551A1 Spiropiperidine derivatives as melanocortin receptor agonists
12/16/1999CA2334545A1 Treatment of anti-estrogen resistant breast cancer using rxr modulators
12/16/1999CA2334296A1 Enhanced intra vaginal devices
12/16/1999CA2329685A1 Proteins regulating gene expression
12/16/1999CA2328906A1 Acrosomal sperm protein and uses thereof
12/16/1999CA2321273A1 Novel analgesic agents
12/16/1999CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999CA2319651A1 H1-histamine receptor antagonists
12/16/1999CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999CA2318055A1 .beta.2-adrenergic receptor agonists
12/15/1999EP0963983A1 Indol-2-ones as serotonin modulators
12/15/1999EP0963201A1 Transdermal application of naturally occurring steriod hormones
12/15/1999EP0646008B1 Minimizing progestin associated breakthrough bleeding
12/15/1999CN1238781A Heptapeptide oxytocin analofues
12/15/1999CN1238773A Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
12/14/1999US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999US6001847 Chemical compounds
12/14/1999US6001830 Heterocyclic compounds
12/14/1999US6001599 Nucleotide sequences coding zona pellucida protein; for the isolation of nucleic acid sequences coding human zona pellucida protein; antifertility agents
12/14/1999US6001596 Growth-associated protease inhibitor heavy chain precursor
12/14/1999US6001353 20α-alpha-hydroxy steroid dehydrogenase related material and methods
12/14/1999CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/09/1999WO1999063115A2 Use of cathepsin s in the diagnosis and treatment of endometriosis
12/09/1999WO1999063079A1 Endometriosis-associated gene
12/09/1999WO1999062929A1 17β-NITRO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES
12/09/1999WO1999062928A1 17β-AMINO AND HYDROXYLAMINO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES
12/09/1999WO1999062902A1 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
12/09/1999WO1999062883A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
12/09/1999WO1999062545A2 GnRH VACCINES FOR SUPPRESSING REPRODUCTIVE BEHAVIOUR IN ANIMALS
12/09/1999WO1999062533A1 Preparation for topical application to the male sexual organ
12/09/1999WO1999062532A1 Corn extract contraceptive
12/09/1999WO1999062523A1 Bridged indenopyrrolocarbazoles
12/09/1999WO1999062509A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension
12/09/1999WO1999052544A9 Regulation of ovarian maturation and function using epidermal growth factor
12/09/1999CA2334117A1 Use of cathepsin s in the diagnosis and treatment of endometriosis
12/09/1999CA2333756A1 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors
12/09/1999CA2329527A1 Endometriosis-associated gene
12/09/1999CA2329435A1 Endogenous nitric oxide synthesis under conditions of low oxygen tension
12/08/1999EP0962225A2 Use of phentolamine for the manufacture of a medicament for the treatment of erectile dysfunction
12/08/1999EP0961616A1 Non-hormonal method of contraception
12/08/1999CN1237979A Conformationally constrained LH-RH analogues, their ues and pharmaceutical composisions containing them
12/07/1999US5998583 BH3 interacting domain death agonist
12/07/1999US5998579 Epimorphin antagonist and process for producing it
12/07/1999US5998481 Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
12/07/1999US5998443 Phosphorous containing benzothiophenes for treating estrogen deficiency
12/07/1999US5998442 Benzo [B] thiophene compounds, and compositions for treating bone loss, and hyperlipidemia
12/07/1999US5998430 Bladder and urinary system disorders
12/07/1999US5998401 Naphthyl compounds, intermediates, compositions, and methods
12/07/1999US5998368 Derivatives of structurally modified VIP and pharmaceutical compositions containing them
12/07/1999CA2161103C Controlled release oxybutynin formulations
12/07/1999CA2020663C Substitution analogues of magainin peptides
12/07/1999CA2004991C Deletion analogues of magainin peptides
12/02/1999WO1999061626A2 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase
12/02/1999WO1999061617A1 Interleukins-21 and 22
12/02/1999WO1999061471A2 Human transmembrane proteins
12/02/1999WO1999061469A2 Prostate growth-associated membrane proteins
12/02/1999WO1999061030A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZOÏC ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-λB
12/02/1999WO1999061023A1 Cocaine receptor binding ligands
12/02/1999WO1999061010A2 Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound
12/02/1999WO1999045886A3 New contraceptive kit for monotherapy
12/02/1999DE19824230A1 Neues Endometriose-assoziiertes Gen Create an endometriosis-associated gene
1 ... 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 ... 557